CREACHEM
Timeline
27 events since 2013Board
Filings
Financial
Establishments
Address
2014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Registered office moved within IxellesNew registered office: Avenue Louise 231, 1050 Ixelles · Previous registered office: Avenue Louise 523, 1050 Ixelles · General meeting of 03-09-20264 points ▸
- General meeting, 03-09-2026
- Registered-office move, Avenue Louise 231, 1050 Ixelles
- 1,000 shares
- Power of attorney, Rodolphe DELMEE
- The deed holds 4 more points.
Annual accounts 2025 filed NBBabbreviated format · 27 days late
2025
Weakest financial year net -€131,475 The net result drops to -€131,475, the lowest from 2013 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0503909258
Registered office moved from Tienen to BrusselsNew registered office: Louisalaan 523, 1050 Brussel · Previous registered office: Albertvest 66, 3300 Tienen · Board meeting of 04-09-20255 points ▸
- Board meeting, 04-09-2025
- Registered-office move, Louisalaan 523, 1050 Brussel
- Power of attorney, Olivier Querinjean
- Power of attorney, Lancelot Decaesstecker
- Power of attorney, Charles Haverbeke
Annual accounts 2024 filed PDFabbreviated format · 29 days late
New sole directorSWEETCH appointed, Karl Booten resigned · Permanent representative: Thibaut Gachet · General meeting of 27-01-20255 points ▸
- General meeting, 27-01-2025
- Director appointment, SWEETCH (sole director)
- Permanent representative, Thibaut Gachet
- Director resignation, Karl Booten (sole director)
- General meeting, 27-06-2024
2024
Annual accounts 2023 filed PDFabbreviated format · 79 days before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 25 days late
Change of role: BOOTEN Karl Emiel Irma, from manager to directorDirector discharge: BOOTEN Karl Emiel Irma (manager) · General meeting of 27-12-20226 points ▸
- General meeting, 27-12-2022
- Registered office clause, Albertvest 66, 3300 Tienen
- Director resignation, BOOTEN Karl Emiel Irma (manager)
- Director discharge, BOOTEN Karl Emiel Irma (manager)
- Director appointment, BOOTEN Karl Emiel Irma
- 1,000 shares
- The deed holds 4 more points.
2022
Annual accounts 2021 filed PDFabbreviated format · 13 days before the deadline
Registered office moved within TienenNew registered office: Albertvest 66 te 3300 Tienen · Previous registered office: Leuvenselaan 172 te 3300 Tienen · General meeting of 16-05-20222 points ▸
- General meeting, 16-05-2022
- Registered-office move, Albertvest 66 te 3300 Tienen
2021
Annual accounts 2020 filed PDFabbreviated format · 65 days before the deadline
2020
Highest result from 2013 to 2025 net €496,945 ▲219% The operating result of €701,688 and the net result of €496,945 are both a record.
Equity above €1m equity €1.0m ▲95.2% Equity rises from €522,243 to €1.0m.
Annual accounts 2019 filed PDFabbreviated format · 76 days late
2019
Equity above €500,000 equity €522,243 ▲42.6% Equity rises from €366,217 to €522,243.
Annual accounts 2018 filed PDFabbreviated format · 69 days late
2018
Annual accounts 2017 filed PDFabbreviated format · 58 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 53 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 28 days late
2015
Equity above €200,000 equity €258,624 ▲54.6% With a profit in every financial year since 2013, equity grows to €258,624.
Annual accounts 2014 filed PDFabbreviated format · 21 days late
2014
Equity above €150,000 equity €167,314 ▲69.9% With a profit in every financial year since 2013, equity grows to €167,314.
Annual accounts 2013 filed PDFabbreviated format · 53 days late
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
CREACHEM was incorporated on 7 February 2013.1 The registered office moved to Tienen in 2022, to Brussels in 2025 and to Ixelles in 2026.234 SWEETCH is sole director of the company, appointed by deed of 03-04-2025.5 Total assets went from €1.1m in 2018 to €1.2m in 2025 and headcount from 0.3 full-time equivalents in 2018 to 0.3 in 2024.6